An IARC evaluation of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans as risk factors in human carcinogenesis

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 2, 1998, Pages 755-760

  McGregor, Douglas B ^a   Partensky, Christiane ^a   Wilbourn, Julian ^a   Rice, Jerry M ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; Aryl hydrocarbon receptor; Cancer; Carcinogenesis; Carcinogenic mechanism; Contaminated rice oil; Dioxin; Industrial exposure; Polychlorinated dibenzo p dioxins; Polychlorinated dibenzofurans

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOASSAY; CANCER RISK; CARCINOGENESIS; CONFERENCE PAPER; FOLLOW UP; HUMAN; NONHUMAN; OCCUPATIONAL ACCIDENT; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ANIMALIA;

EID: 0031860431     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106755     Document Type: Conference Paper

References (50)

1. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 69: Polychlorinated Dibenzo-para-dioxins and Polychlorinated Dibenzofurans. Lyon:International Agency for Research on Cancer, 1997.
2. IARC. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol 15: Some Fumigants, the Herbicides 2,4-D and 2,4,5-T, Chlorinated Dibenzodioxins and Miscellaneous Industrial Chemicals. Lyon:International Agency for Research on Cancer, 1977.
3. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Suppl 7: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42. Lyon:International Agency for Research on Cancer, 1987.
4. Vos JG, Koeman JH, van der Maas HL, ten Noever de Brauw MC, de Vos RH. Identification and toxicological evaluation of chlorinated dibenzofuran and chlorinated naphthalene in two commercial polychlorinated biphenyls. Food Cosmet Toxicol 8:625-633 (1970).
5. Rappe C, Buser H-R, Bosshardt, H-P. Identification and quantification of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) in 2,4,5-T ester formulations and Herbicide Orange. Chemosphere 7:431-438 (1978).
6. Rappe C, Gara A, Buser H-R. Identification of polychlorinated dibenzofurans (PCDFs) in commercial chloropnenol formulations. Chemosphere 7:981-991 (1978).
7. WHO/EURO. Dioxins and Furans from Municipal Incinerators. Environmental Health Ser 17. Copenhagen:World Health Organization Regional Office for Europe, 1987.
8. Jager J. PCDD/F and PCB emission from steel producing, processing and reclamation plants with varying input. Toxicol Environ Chem 40:201-211 (1993).
9. Rappe C, Wågman N. Trace analysis of PCDDs and PCDFs in unbleached and bleached pulp samples. Organohalogen Compounds 23:377-381 (1995).
10. Rappe C, Kjeller L-O, Kulp S-E, de Wit C, Hasselsten I, Palm O. Levels, profile and pattern of PCDDs and PCDFs in samples related to the production and use of chlorine. Chemosphere 23:1629-1636 (1991).
11. Rappe C, Buser H-R, Dodet B, O'Neill IK, eds. Environmental Carcinogens: Methods of Analysis and Exposure Measurement. Vol 11: Polychlorinated Dioxins and Dibenzofurans, IARC Sci Publ No 108. Lyon:International Agency for Research on Cancer, 1991.
12. Svensson B-G, Barregård L, Sällsten G, Nilsson A, Hansson M, Rappe C. Exposure to polychlorinated dioxins (PCDD) and dibenzofurans (PCDF) from graphite electrodes in a chloralkali plant. Chemosphere 27:259-262 (1993).
13. Stringer RL, Costner P, Johnston PA. PVC manufacture as a source of PCDD/Fs. Organohalogen Compounds 24:119-123 (1995).
14. Hansson M, Barregård L, Sällsren G, Svensson B-G, Rappe C. Polychlorinated dibenzo-p-dioxin and dibenzofuran levels and patterns in PVC and chloralkali industry workers. Int Arch Occup Environ Health 70:51-56 (1997).
15. Raope C, Kjeller L-O, Marklund S, Nygren M. Electrical PCB accidents, an update. Chemosphere 15:1291-1295 (1986).
16. Kuratsune M, Yoshimura T, Matsuzaka J, Yamaguchi A. Epidemiologic study on Yusho, a poisoning caused by ingestion or rice oil contaminated with a commercial brand of polychlorinated biphenyls. Environ Health Perspect 1:119-128 (1972).
17. Hsu S-T, Ma C-I, Hsu SK-H, Wu S-S, Hsu NH-M, Yeh C-C, Wu S-B. Discovery and epidemiology of PCB poisoning in Taiwan: a four-year follow-up. Environ Health Perspect 59:5-10 (1985).
18. Fingerhut MA, Halperin WE, Marlow DA, Piacitelli LA, Honchar PA, Sweeney MH, Greife AL, Dill PA, Steenland K, Suruda AJ. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. New Engl J Med 324:212-218 (1991).
19. Hooiveld M, Heederik D, Bueno de Mesquita HB. Preliminary results of the second follow-up of a Dutch cohort of workers occupationally exposed to phenoxy herbicides, chlorophenols and contaminants. Organohalogen Compounds 30:185-189 (1996).
20. Ott MG, Zober A. Cause specific mortality and cancer incidence among employees exposed ro 2,3.7,8-TCDD after a 1953 reactor accident. Occup Environ Med 53:606-612 (1996).
21. Flesch-Janys D, Berger J, Gurn P, Manz A, Nagel S, Waltsgott H, Dwyer JH. Exposure ro polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. Am J Epidemiol 142:1165-1176 (1995).
22. Bertazzi PA, Pesatori AC, Consonni D, Tironi A, Landi MT, Zochetti C. Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. Epidemiology 4:398-406 (1993).
23. Kogevinas M, Becher H, Benn T, Bertazzi PA, Boffetta P, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D, Fingerhut M et al. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols and dioxins; an expanded and updated international cohort study. Am J Epidemiol 145:1061-1075 (1997).
24. Ketchum N, Akhtar F. The Air Force Health Study: An Epidemiologic Investigation of Health Effects in Air Force Personnel Following Exposure to Herbicides, Mortality Update 1996. Interim Tech Rpt AL/AO-TR-1996-0068. Brooks Air Force Base, Texas:Armstrong Laboratory, 1996.
25. Fingerhut MA, Halperin WE, Marlow DA, Piacitelli LA, Honchar PA, Sweeney MH, Greife AL, Dill PA, Steenland K, Suruda AJ. Mortality Among U.S. Workers Employed in the Production of Chemicals Contaminated with 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD). NTIS PB 91-125971. Cincinnati, OH:National Institute for Occupational Safety and Health, 1991.
26. Toth K, Somfai-Relle S, Sugar J, Bence J. Carcinogenicity testing of herbicide 2,4,5-trichlorophenoxyethanol containing dioxin and of pure dioxin in Swiss mice. Nature 278:548-549 (1979).
27. 1 Mice (Gavage Study). TR-209. Research Triangle Park, NC:U.S. National Toxicology Program, 1982.
28. Della Porta G, Dragani TA, Sozzi G. Carcinogenic effects of infantile and long-term 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment in the mouse. Tumori 73:99-107 (1987).
29. Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Fauson LE, Park CN, Barnard SD et al. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 46:279-303 (1978).
30. Rao M, Subbarao V, Prasad J, Scarpelli D. Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the Syrian golden hamster. Carcinogenesis 9:1677-1679 (1988).
31. U.S. NTP. Carcinogenesis Bioassay of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (CAS No 1746-01-6) in Swiss-Webster Mice (Dermal Study). TR-201. Research Triangle Park, NC:U.S. National Toxicology Program, 1982.
32. U.S. NTP. Bioassay of a Mixture of 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin and l,2,3,7,8,9-Hexachlorodibenzo-p-dioxin (Gavage) for Possible Carcinogenicity (CAS No 57653-85-7 and CAS No 19408-74-3). TR-198. Bethesda, MD:National Cancer Institute, 1980.
33. U.S. NTP. Bioassay of a Mixture of 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin and l,2,3,7,8,9-Hexachlorodibenzo-p-dioxin (Dermal Study) for Possible Carcinogenicity (CAS No 57653-85-7 and CAS No 19408-74-3). TR-202. Bethesda, MD: National Cancer Institute, 1980.
34. U.S. NTP. Bioassay of Dibenzo-p-dioxin for Possible Carcinogenicity (CAS No 262-12-4). TR-122. Bethesda, MD:U.S. National Cancer Institute, 1979.
35. Ikeda M, Kuratsune M, Nakamura Y, Hirohata T. A cohort study on mortality of Yusho patients - a preliminary report. Fukuoka Acta Med 78:297-300 (1986).
36. Ikeda M, Yoshimura T. Survival of patients. In: Yusho. A Human Disaster Caused by PCBs and Related Compounds (Kuratsune M, Yoshimura H, Hori Y, Okumura M, Masuda Y, eds). Fukuoka:Kyushu University Press, 1996;316-323.
37. Yu M-L, Guo Y-LL, Hsu CC, Rogan WJ. Increased mortality from chronic liver disease and cirrhosis 13 years after the Taiwan Yucheng ('oil disease') incident. Am J Ind Med 31:172-175 (1997).
38. Poland A, Palen D, Glover E. Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature 300:271-273 (1982).
39. Hébert CD, Harris MW, Elwell MR, Birnbaum LS. Relative toxicity and tumor-promoting ability of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 2,3,4,7,8-pentachlorodibenzofuran (PCDF), and 1,2,3,4,7,8-hexachlorodibenzofuran (HCDF) in hairless mice. Toxicol Appl Pharmacol 102:362-377 (1990).
40. Nishizumi M, Masuda Y. Enhancing effect of 2,3,4,7,8-pentachlorodibenzofuran and 1,2,3,4,7,8-hexachlorodibenzofuran on diethylnitrosamine hepatocarcinogenesis in the rat. Cancer Lett 33:333-339 (1986).
41. Waern F, Flodström S, Busk L, Kronevi T, Nordgren I, Ahlborg UG. Relative liver tumour promoting activity and toxicity orsome polychlorinated dibenzo-p-dioxin- and dibenzofuran-congeners in female Sprague-Dawley rats. Pharmacol Toxicol 69:450-458 (1991).
42. Burleson GR, Lebrec H, Yang YG, Ibanes JD, Pennington KN, Birnbaum LS. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fundam Appl Toxicol 29:40-47 (1996).
43. Law MR, Hackshaw AK. Environmental tobacco smoke. Br Med Bull 52:22-34 (1996).
44. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 59: Hepatitis Viruses. Lyon:International Agency for Research on Cancer, 1994.
45. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol 44:92-95 (1994).
46. Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH. Independent and additive effect of modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol 24:271-276 (1996).
47. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 276:906-908 (1996).
48. Hsu SH, Chan CY, Tarn TN, Lin SH, Tang KC, Lee SD. The liver biochemical tests and serological markers of hepatitis B virus in the very old-aged population in Taiwan. Chung Hua I Hsueh Tsa Chih Taipei 57:16-21 (1996).
49. McGregor DB, Pangrekar J, Rosenkranz HS, Klopman G. A reexamination of the low prevalence of carcinogens in an early carcinogen screen. Regul Toxicol Pharmacol 19:97-105 (1994).
50. Gold LS, Sawyer CB, Magaw R, Backamn GM, de Veciana M, Levinson R, Hooper NK, Havender WR, Bernstein L, Peto R et al. A carcinogenic potency database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319 (1984).